Patient Recruitment and Treatment
cancers of the head and neck region, tumor, tumors, neurological or psychiatric diseases
ONCOLOGY, TUMOR, TUMORS
The inclusion criteria for this trial included histologically confirmed tumors in the head and neck region, scheduled radiotherapy or chemoradiation, as indicated by the respective multidisciplinary tumor board, an age ≥18 years, a Karnofsky performance score ≥50%, and provision of written informed consent. Patients with significant neurological or psychiatric diseases and patients unable to provide informed consent were excluded from this trial.All patients with histologically confirmed cancers of the head and neck region, scheduled for (chemo)radiotherapy at the Department of Radiation Oncology, University of Freiburg Medical Center, Germany, were screened for inclusion in the trial. Consenting patients were randomized by block randomization between the standard-of-care monitoring and ePRO monitoring during the course of radiation treatment, and 50 patients were included in each trial arm. Protocol details have been published previously [